Financials

  • Market Capitalization 604.17 M
  • Employee 246
  • Founded 2013
  • CEO N/A
  • Website www.arvinas.com
  • Headquarter Delaware, United States
  • FIGI BBG00LW7YK82
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
34.62
Rapporto prezzo/fatturato
1.75

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2788
AUTL
Autolus Therapeutics plc - American Depositary Shares
2.36 USD+1.29%-3.28%+62.76%+49.37%628.14 M USD
2796
RGNX
REGENXBIO Inc. - Common Stock
9.37 USD-0.11%-15.89%-2.90%-30.23%618.54 M USD
2820
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
6.03 USD0.00%+9.24%+7.68%-34.53%599.67 M USD
2838
CAPR
Capricor Therapeutics, Inc. - Common Stock
10.06 USD+7.48%+47.94%+227.69%+60.19%584.88 M USD

Notizie